These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 4553612

  • 1. Use of drugs in cardiogenic shock due to acute myocardial infarction.
    Gunnar RM, Loeb HS.
    Circulation; 1972 May; 45(5):1111-24. PubMed ID: 4553612
    [No Abstract] [Full Text] [Related]

  • 2. Drug therapy in cardiogenic shock.
    Ramdohr B.
    Int J Clin Pharmacol; 1973 Apr; 7(2):118-26. PubMed ID: 4731279
    [No Abstract] [Full Text] [Related]

  • 3. Management of shock in acute myocardial infarction.
    Pema PJ.
    J Am Osteopath Assoc; 1971 Mar; 70(7):692-702. PubMed ID: 4926966
    [No Abstract] [Full Text] [Related]

  • 4. Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy.
    Takkunen J, Oilinki O, Huhti E, Vuopala U, Koivisto O.
    Acta Med Scand; 1972 Sep; 192(3):165-70. PubMed ID: 5055261
    [No Abstract] [Full Text] [Related]

  • 5. The failing myocardium. I. Drug management.
    Loeb HS, Rahimtoola SH, Gunnar RM.
    Med Clin North Am; 1973 Jan; 57(1):167-85. PubMed ID: 4143986
    [No Abstract] [Full Text] [Related]

  • 6. [Drug therapy in cardiogenic shock].
    Wenger R.
    Int J Clin Pharmacol; 1973 Apr; 7(2):127-31. PubMed ID: 4147221
    [No Abstract] [Full Text] [Related]

  • 7. Cardiogenic shock and its current treatment.
    Willerson JT.
    Tex Med; 1975 Apr; 71(4):49-59. PubMed ID: 1135757
    [No Abstract] [Full Text] [Related]

  • 8. Shock in myocardial infarction--medical treatment.
    Kuhn LA.
    Am J Cardiol; 1970 Dec; 26(6):578-87. PubMed ID: 4938984
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction.
    Ratshin RA, Rackley CE, Russell RO.
    Circulation; 1972 Jan; 45(1):127-39. PubMed ID: 5007030
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inotropic agents in the treatment of cardiogenic shock.
    Bourdarias JP, Dubourg O, Gueret P, Ferrier A, Bardet J.
    Pharmacol Ther; 1983 Jan; 22(1):53-79. PubMed ID: 6361798
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Drugs in shock treatment].
    Dietzman RH, Motsay GJ, Lillehei RC.
    Internist (Berl); 1971 Mar; 12(3):103-7. PubMed ID: 4927712
    [No Abstract] [Full Text] [Related]

  • 18. Cardiogenic shock.
    Rackley CE, Russell RO, Mantle JA, Rogers WJ.
    Cardiovasc Clin; 1981 Mar; 11(3):15-24. PubMed ID: 7214388
    [Abstract] [Full Text] [Related]

  • 19. Serial hemodynamics during intra-aortic balloon counterpulsation for cardiogenic shock.
    Dilley RB, Ross J, Bernstein EF.
    Circulation; 1973 Jul; 48(1 Suppl):III99-104. PubMed ID: 4721288
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.